Pyogenic spondylodiscitis following anti-interleukin-6 therapy in a patient with rheumatoid arthritis (implication of hematogenous infection risk in degenerative intervertebral discs): A case report and review of the literature-Reference-Cited by-同舟云学术

Pyogenic spondylodiscitis following anti-interleukin-6 therapy in a patient with rheumatoid arthritis (implication of hematogenous infection risk in degenerative intervertebral discs): A case report and review of the literature

Published:2016-09 Issue:5 Volume:21 Page:694-697
ISSN:0949-2658
Container-title:Journal of Orthopaedic Science
language:en
Short-container-title:Journal of Orthopaedic Science

Author:

Tsujimoto Takeru,Takahata Masahiko,Kokabu Terufumi,Matsuhashi Megumi,Iwasaki Norimasa

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine,Surgery

Reference11 articles.

1. Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry;van Dartel;Ann Rheum Dis,2013

2. Severe pyogenic infections in patients taking infliximab: a regional cohort study;Maillard;Joint Bone Spine,2005

3. Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis;Koike;Mod Rheumatol,2009

4. Pyogenic spondylitis;Cheung;Int Orthop,2012

5. Spondylodiscitis: update on diagnosis and management;Gouliouris;J Antimicrob Chemother,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman Disease;Internal Medicine;2023-02-01

2. The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature;Life;2021-03-20

3. Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review;Rheumatology International;2021-02-12

4. Methylprednisolone/tocilizumab;Reactions Weekly;2016-12